Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM “ April 25, 2024 “ 07:00 PM CET (Euronext Brussels: OXUR), a biopharmaceutical company headquartered...
Publication Annual Report “ Annual Shareholders' Meeting Leuven, BELGIUM “ April 15, 2024 “ 05:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has...
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC Leuven, BELGIUM “ April 11, 2024 “ 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding ProgramEleventh tranche fully issued and paid-up Leuven, BELGIUM, 10 April 2024 07.00 PM CET Oxurion NV (Euronext Brussels:...
Postponement Annual Shareholders Meeting - Amendment financial calendarLeuven, BELGIUM “ April 5, 2024 “ 02:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in...
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM “ March 28, 2024 “ 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended version Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion...
Information on the Total No. of Voting Rights following Conversion from Atlas
OXURION announces its presence at the Paris SmallCapevent on March 28, 2024. Leuven, BELGIUM - March 25, 2024 - 7:00 p.m, Oxurion NV (Euronext Brussels : OXUR), a Leuven-based biopharmaceutical...
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM “ March 22, 2024 “ 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...